| 1例慢性阻塞性肺疾病急性加重期患者出现皮下淤血后的药学监护 |
| |
| 引用本文： | 徐玲,李祥鹏,翁旗,徐红冰.1例慢性阻塞性肺疾病急性加重期患者出现皮下淤血后的药学监护[J].中国医院用药评价与分析,2013(7):665-667. |
| |
| 作者姓名： | 徐玲 李祥鹏 翁旗 徐红冰 |
| |
| 作者单位： | [1]南方医科大学附属郑州人民医院,郑州450003 [2]青岛大学医学院附属医院,山东青岛266003 [3]杭州市第一人民医院,杭州310006 [4]上海交通大学附属第一人民医院,上海200080 |
| |
| 摘 要： | 目的：探讨对慢性阻塞性肺疾病急性加重期患者进行药学监护的内容和模式。方法：结合慢性阻塞性肺疾病急性加重期治疗原则和不良反应相关性评价,分析治疗方案,为1例慢性阻塞性肺疾病急性加重期患者出现皮下淤血后实施全程的药学监护。结果：从抗感染方案的制定到止血方案的制定,通过药学监护,及时发现了存在的药物治疗问题以及可能引起皮下出血不良反应的药物,避免严重后果的出现。结论：对慢性阻塞性肺疾病加重期患者实施药学监护,可优化治疗方案,及时发现可能引起不良反应的药物而避免严重后果的出现,提高了药物治疗的安全性和有效性。
|
| 关 键 词： | 慢性阻塞性肺疾病 药学监护 皮下淤血 不良反应 |
Pharmaceutical Care for One Case of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Sugillation |
| |
| XU Ling,LI Xiang-peng,WENG Qi,xu Hong-bing.Pharmaceutical Care for One Case of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Sugillation[J].Evaluation and Analysis of Drug-Use in Hospital of China,2013(7):665-667. |
| |
| Authors: | XU Ling LI Xiang-peng WENG Qi xu Hong-bing |
| |
| Institution: | 1. Zhengzhou People＇s Hospital Affiliated to Southern Medical University, Zhengzhou 450003, China; 2. The Affiliated Hospital of Medical College Qingdao University, Shandong Qingdao 266003, China; 3. Hangzhou First People＇ s Hospital, Hangzhou 310006, China; 4. Shanghai Jiaotong University Affiliated First People＇s Hospital, Shanghai 200080, China) |
| |
| Abstract: | OBJECTIVE： To explore the contents and modes of pharmaceutical care for patients with acute exacerbation of chronic obstructive pulmonary disease （AECOPD） and sugillation. METHODS： Based on the therapeutic principle of AECOPD and the correlation evaluation on adverse reaction, we analyzed the therapeutic schedule and carried out full range of pharmaceutical care for a case of AECOPD with sugillation. RESULTS： In formulating of anti-infective regimen and hemostatic regimen, with pharmaceutical care, serious consequence was avoided because of the timely detection of medication problem and the possible drugs that might induce the adverse reaction of sugillation. CONCLUSION： The pharmaceutical care for AECOPD can optimize therapeutic regimen and discover in time the possible drug that might induce adverse reaction thus avoiding the serious consequence which contributed to enhanced safety and effectiveness of medication. |
| |
| Keywords: | Chronic obstructive pulmonary disease Pharmaceutical care Sugillation Adverse reaction |
| 本文献已被 维普 等数据库收录！ |
|
